3 views on whether states should legalize marijuana

This November, voters in Colorado, Oregon, and Washington will consider ballot measures to legalize and regulate marijuana, much as alcohol and tobacco are taxed and regulated. In this first in a series of "one minute debates" for election 2012, three writers give their brief take on the issue.

3. A middle path: Find ways to access medical benefits without legalization

The media and marijuana legalization advocates would have Americans believe the only choices for marijuana policy are legalization or strict prohibition. Neither approach is right.

Marijuana should not be sold on the open market. Legal alcohol, tobacco, and prescription drugs kill more than 500,000 people a year. Research tells us that access and availability lead to greater use, and big tobacco showed that legal industries can play down harmful health effects of their products.

Neither is there any assurance, under legalization, that the underground market would disappear, because that market could very easily adapt to and undercut a legal, taxed product like marijuana.

But the United States should also not focus only on enforcement. Few people are in prison or jail for mere possession of marijuana, but even an arrest record can hamper chances for employment, education loans, or other public assistance. Laws that provide for a sanction but do not penalize an offender's future should be considered. Drug courts – which offer treatment with accountability – and probation programs that focus on intervention also make sense.

Finally, though existing medical marijuana programs represent little more than de facto legalization, cannabinoids – the chemical compounds present in marijuana plants – may have medical utility worth pursuing. Research should identify them and standardize their dosage and delivery form.

Just as we do not smoke opium to gain the medical effects of morphine, we should not smoke marijuana to obtain therapeutic benefits. Nonsmoked formulations (like Sativex, a mouth spray under Food and Drug Administration review) offer a safe, scientific, tested way to properly medicalize cannabinoids.

Such drugs may not mollify marijuana enthusiasts who want a "medical" excuse to smoke marijuana. But they represent a common-sense marijuana policy that the US would do well to follow.

Kevin A. Sabet, PhD, has worked on national drug policy under Presidents Barack Obama, George W. Bush, and Bill Clinton.

3 of 3

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

You've read  of  free articles. Subscribe to continue.